CDK5R1 and Alzheimer disease: Spreafico et al. have observed that NEAT1 expression levels were elevated in the temporal cortex and hippocampus in patients with AD, and have further observed a strong positive correlation between NEAT1 expression and cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1), which was closely associated with AD onset and progression.